YGEN.L Stock Analysis
YG
Uncovered
Yourgene Health PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.022
Dividend yield
—
Shares outstanding
3 176.96 B
Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. The firm primarily develops, manufactures, and commercializes molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. The Company’s segments include Genomic Technologies segment provides the in vitro diagnostic products, software and instrumentation, and Genomic Services segment provide services to clinicians, third party clinical service providers and contract research organizations. The Company’s flagship in vitro diagnostic products include non-invasive prenatal tests for Down’s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests and DPYD genotyping. The firm has a range of deoxyribonucleic (DNA) sample preparation platforms, powered by Ranger Technology, the Yourgene LightBench and Yourgene QS250, ideal for cell-free DNA applications in non-invasive prenatal tests and oncology including liquid biopsy.